Dublin, March 19, 2020 (GLOBE NEWSWIRE) -- The "North America Tumor Ablation Market, by Treatment, by Technology, by Application, by Country, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
The North America Tumor Ablation Market is expected to witness market growth of 9.4% CAGR during the forecast period (2019-2025).
One of the facilitating factors of revolutionary tumor ablation treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Key Topics Covered
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.4.1 North America Tumor Ablation Market, by Treatment
1.4.2 North America Tumor Ablation Market, by Technology
1.4.3 North America Tumor Ablation Market, by Application
1.4.4 North America Tumor Ablation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Moves: (Acquisition and Mergers: 2019-Oct - 2016-Jan) Leading Players
Chapter 4. North America Tumor Ablation Market by Treatment
4.1 North America Surgical Ablation Market by Country
4.2 North America Laparoscopic Ablation Market by Country
4.3 North America Percutaneous Ablation Market by Country
Chapter 5. North America Tumor Ablation Market by Technology
5.1 North America Radiofrequency Ablation Market by Country
5.2 North America Microwave Ablation Market by Country
5.3 North America Cryoablation Market by Country
5.4 North America Irreversible Electroporation Market by Country
5.5 North America Other Technology Market by Country
Chapter 6. North America Tumor Ablation Market by Application
6.1 North America Liver Cancer Market by Country
6.2 North America Breast Cancer Market by Country
6.3 North America Lung Cancer Market by Country
6.4 North America Kidney Cancer Market by Country
6.5 North America Prostate Cancer Market by Country
6.6 North America Others Tumor Ablation Market by Country
Chapter 7. North America Tumor Ablation Market by Country
7.1 US Tumor Ablation Market
7.2 Canada Tumor Ablation Market
7.3 Mexico Tumor Ablation Market
7.4 Rest of North America Tumor Ablation Market
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments
188.8.131.52 Acquisition and Mergers
184.108.40.206 Product Launches and Product Expansions
8.2 Johnson and Johnson (Ethicon, Inc.)
8.3 Boston Scientific Corporation
8.4 Misonix, Inc.
8.5 EDAP TMS S.A.
8.6 Theraclion S.A.
8.7 AngioDynamics, Inc.
8.8 Mermaid Medical A/S
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.10 SonaCare Medical, LLC
For more information about this report visit www.researchandmarkets.com/r/3sgc3i
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900